Influence of border-age on survival of sporadic renal cell carcinoma: young adults versus octogenarians

被引:0
作者
Mehmet Çağlar Çakıcı
Erdem Kısa
Mehmet Yiğit Yalçın
Özgür Efiloğlu
Cem Yücel
Gökhan Atış
Yusuf Özlem İlbey
Asıf Yıldırım
机构
[1] Istanbul Medeniyet University Goztepe Training and Research Hospital,Department of Urology
[2] Health Sciences University,Department of Urology
[3] Izmir Tepecik Training and Research Hospital,undefined
来源
International Urology and Nephrology | 2020年 / 52卷
关键词
Border-age; Octogenarian; Renal cell carcinoma; Sporadic; Survival; Young adult;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2087 / 2095
页数:8
相关论文
共 74 条
[1]  
Corcoran AT(2013)A review of contemporary data on surgically resected renal masses–benign or malignant? Urology 81 707-713
[2]  
Russo P(2012)Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems 1996–2010 JAMA 307 2400-2409
[3]  
Lowrance WT(1999)Rising incidence of renal cell cancer in the United States JAMA 281 1628-1631
[4]  
Smith-Bindman R(2002)Renal cell carcinoma in young adults: incidence, disease outcome and review of the literature Arch Esp Urol 55 969-975
[5]  
Miglioretti DL(2004)Natural history and clinical outcome of sporadic renal cortical tumors diagnosed in the young adult Urology 63 41-45
[6]  
Johnson E(1991)Renal cell carcinoma in young and old patients. Comparison of prognostic pathologic variables (cell type, tumor grade and stage, and DNA ploidy pattern) and their impact on disease outcome Urology 38 1-5
[7]  
Chow WH(2004)Young age is an independent prognostic factor for survival of sporadic renal cell carcinoma J Urol 171 2160-2165
[8]  
Devesa SS(2005)Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses J Urol 173 1893-1896
[9]  
Warren JL(2008)Renal cell carcinoma in young and old patients—is there a difference? J Urol 180 1262-1266
[10]  
Fraumeni JF(2007)Renal cell carcinoma in adults 40 years old or less: young age is an independent prognostic factor for cancer-specific survival Eur Urol 51 980-987